EGFR and thyroid gland papillary carcinoma: However, recent research has shown that miR-137 was downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR [40], and it could act as a tumor suppressor in papillary thyroid carcinoma [41].